alone, an estimated 11.3% of the population, equivalent to around 38.4 million individuals, are affected by DM, primarily Type 2 diabetes
However, study results for some are sparse, or have not been published in scientific journals
doi: 10.3389/fimmu.2024.1353787 86 DengHKanALyuNHeMHuangXQiaoSet al
Through specialized delivery systems such as microneedles or permeation boosters, the medication steadily enters the bloodstream, potentially offering more stable drug levels compared to injections
What are the side effects of the new medication, and how do they compare with Ozempics side effects
*Correspondence: Menghua Dai [email protected] Zhao [email protected] This article was submitted to Gastrointestinal Cancers, a section of the journal Frontiers in Oncology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers